UPDATED Apr 29, 2024
Companies which grew earnings more than 50% in the last year.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SDOS | kr1.72 | -0.6% | -20.4% | kr78.4m | n/a | PS1.2x | n/a | n/a | Healthcare | ||
NORVA | kr25.80 | -0.4% | -8.2% | kr4.7b | kr32.75 | PE20.9x | E9.3% | n/a | Commercial Services | ||
NORDIG | kr0.65 | 15.2% | 10.8% | kr157.0m | n/a | PS12.6x | n/a | n/a | Software | ||
HYCO | kr1.10 | -13.4% | -49.1% | kr8.8m | n/a | PB1.3x | n/a | n/a | Capital Goods | ||
FNOX | kr64.22 | 3.2% | -8.9% | kr39.2b | kr71.50 | PE63.9x | E21.5% | 0.3% | Software | ||
VBG B | kr379.50 | 10.0% | 123.0% | kr9.5b | kr430.00 | PE15.2x | E6.6% | 1.8% | Capital Goods | ||
AVT B | kr5.50 | 7.0% | 48.6% | kr310.6m | kr5.90 | PE29.3x | E17.3% | n/a | Capital Goods | ||
MAGLE | kr30.00 | -3.2% | -0.7% | kr324.0m | kr40.00 | PE26.5x | E35.4% | n/a | Pharmaceuticals & Biotech | ||
RO | kr0.84 | -1.6% | 9.4% | kr186.2m | n/a | PS5.7x | n/a | 0% | Commercial Services | ||
TANGI | kr0.014 | 3.0% | -77.3% | kr5.3m | n/a | PB0.4x | n/a | n/a | Consumer Services |